Thomas Edward Gibbs's Net Worth

-$19.2 Thousand

Estimate Recalculated Sep 18, 2024 03:13PM EST

Who is Thomas Edward Gibbs?

Thomas Edward Gibbs does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vanda Pharmaceuticals Inc., and OptiNose, Inc..

SEC CIK

Thomas Edward Gibbs's CIK is 0001639012

Past Insider Trading and Trends

2019 was Thomas Edward Gibbs's most active year for acquiring shares with 3 total transactions. Thomas Edward Gibbs's most active month to acquire stocks was the month of March. 2019 was Thomas Edward Gibbs's most active year for disposing of shares, totalling 1 transactions. Thomas Edward Gibbs's most active month to dispose stocks was the month of February. 2018 saw Thomas Edward Gibbs paying a total of $25,380.00 for 2,000 shares, this is the most they've acquired in one year. In 2019 Thomas Edward Gibbs cashed out on 2,000 shares for a total of $16,480.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $5.12

SVP, Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 20
Form 3
—
0
—
—
0
No matching records found

OptiNose, Inc. (OPTN) Snapshot price: $0.99

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+106.63%
2.77K
$5.64
$15,611.52
5.36K
Jun 28
Form 4
—
0
—
—
0
Apr 17
Form 4
-43.52%
-2.00K
$8.24
-$16,480.00
2.6K
Mar 7
Form 4
—
0
—
—
0
Feb 28
Form 4
+100.76%
2K
$12.69
$25,380.00
3.98K
Aug 15
Form 4
—
0
—
—
0
Oct 12
Form 3
—
0
—
—
0
No matching records found